Entity
Description
Value proposition
Turning Cancer’s Energy Dependency Against Itself: a Shift in Precision Drug Delivery
INATHERYS is a clinical-stage biotech advancing precision drug delivery, turning cancer’s energy dependency against itself.
Our lead asset, an ADC targeting CD71/TfR1, is designed to address critical needs in treating proliferative cancers.
Inatherys, biotechnology company : monoclonal antibodies
Inatherys is a biotechnology company developing monoclonal antibodies for therapies
https://www.inatherys.com/
Catalyst interactions
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Banque Populaire Banking | Banque Populaire Banking | Other 26 Mar 2025 | | |
 HEC Paris Higher Education | HEC Paris Higher Education | Other 30 Nov 2024 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 16 Apr 2025 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 16 Apr 2025 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 26 Mar 2025 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 31 Jan 2025 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 16 Apr 2025 | | |
 STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Other 30 Nov 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Nov 2024 | | |
Social network dynamics
Similar entities
BETA
Loading...
Last news Show all articles
Loading...